165 related articles for article (PubMed ID: 15119492)
1. Rectal function following permanent prostate brachytherapy.
Merrick GS; Butler WM
W V Med J; 2004; 100(1):18-20. PubMed ID: 15119492
[TBL] [Abstract][Full Text] [Related]
2. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
[TBL] [Abstract][Full Text] [Related]
3. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland.
Merrick GS; Wallner KE; Butler WM
J Urol; 2003 May; 169(5):1643-52. PubMed ID: 12686802
[TBL] [Abstract][Full Text] [Related]
4. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
[TBL] [Abstract][Full Text] [Related]
5. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
[TBL] [Abstract][Full Text] [Related]
6. Long-term rectal function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
[TBL] [Abstract][Full Text] [Related]
7. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
Crook JM; Potters L; Stock RG; Zelefsky MJ
Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
[TBL] [Abstract][Full Text] [Related]
8. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
Phan J; Swanson DA; Levy LB; Kudchadker RJ; Bruno TL; Frank SJ
Cancer; 2009 May; 115(9):1827-39. PubMed ID: 19248043
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy.
Price JG; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):842-7. PubMed ID: 23845840
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE
Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216
[TBL] [Abstract][Full Text] [Related]
11. Utilization of a self-administered questionnaire to assess rectal function following prostate brachytherapy.
Blatt HJ; Abel LJ; Stipetich RL; Galbreath RW; Lief JH; Butler WM; Merrick GS
Urol Nurs; 2001 Oct; 21(5):356-9. PubMed ID: 11998302
[TBL] [Abstract][Full Text] [Related]
12. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
13. Rectal complications after prostate brachytherapy.
Shah SA; Cima RR; Benoit E; Breen EL; Bleday R
Dis Colon Rectum; 2004 Sep; 47(9):1487-92. PubMed ID: 15486745
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications.
Han BH; Wallner KE
Int J Cancer; 2001 Dec; 96(6):372-8. PubMed ID: 11745508
[TBL] [Abstract][Full Text] [Related]
15. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
[TBL] [Abstract][Full Text] [Related]
16. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors.
Shah JN; Ennis RD
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):817-24. PubMed ID: 16297567
[TBL] [Abstract][Full Text] [Related]
17. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
[TBL] [Abstract][Full Text] [Related]
18. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
Kishan AU; Kupelian PA
Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
20. The dosimetry of brachytherapy-induced erectile dysfunction.
Merrick GS; Butler WM
Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
